- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]isonicotinamide hydrochloride
| EU orphan designation number: | EU/3/09/685
|
| Active ingredient: | N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]isonicotinamide hydrochloride |
| Indication: | Treatment of pancreatic cancer |
| Sponsor: | Merck KGaA
Frankfurter Straße 250, D-64293 Darmstadt, Deutschland |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 11/11/2009 | Orphan designation | EMEA/OD/069/09 | (2009)8767 of 09/11/2009 |
CONTACT
EU links
Directorate General Health & Consumers